AIM ImmunoTech Inc
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for … Read more
AIM ImmunoTech Inc (AIM) - Total Liabilities
Latest total liabilities as of March 2025: $10.11 Million USD
Based on the latest financial reports, AIM ImmunoTech Inc (AIM) has total liabilities worth $10.11 Million USD as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
AIM ImmunoTech Inc - Total Liabilities Trend (1995–2024)
This chart illustrates how AIM ImmunoTech Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
AIM ImmunoTech Inc Competitors by Total Liabilities
The table below lists competitors of AIM ImmunoTech Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kanoria Chemicals & Industries Limited
NSE:KANORICHEM
|
India | ₹5.77 Billion |
|
2BO
F:2BO
|
Germany | €10.82 Million |
|
Jeju Beer Co. Ltd.
KQ:276730
|
Korea | ₩38.35 Billion |
|
Natural Capsules Limited
NSE:NATCAPSUQ
|
India | ₹1.75 Billion |
|
Zhong Yang Financial Group Limited Ordinary Shares
NASDAQ:TOP
|
USA | $29.11 Million |
|
CATERPILLAR - Dusseldorf Stock Exchang
DU:CAT1
|
Germany | €66.87 Billion |
|
Malam Team
TA:MLTM
|
Israel | ILA1.97 Billion |
|
Aureka Ltd
AU:AKA
|
Australia | AU$731.66K |
Liability Composition Analysis (1995–2024)
This chart breaks down AIM ImmunoTech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AIM ImmunoTech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AIM ImmunoTech Inc (1995–2024)
The table below shows the annual total liabilities of AIM ImmunoTech Inc from 1995 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $9.93 Million | +8.56% |
| 2023-12-31 | $9.15 Million | +352.82% |
| 2022-12-31 | $2.02 Million | +146.34% |
| 2021-12-31 | $820.00K | -75.08% |
| 2020-12-31 | $3.29 Million | -55.01% |
| 2019-12-31 | $7.31 Million | -15.67% |
| 2018-12-31 | $8.67 Million | +57.54% |
| 2017-12-31 | $5.50 Million | +63.08% |
| 2016-12-31 | $3.38 Million | +38.72% |
| 2015-12-31 | $2.43 Million | -45.15% |
| 2014-12-31 | $4.44 Million | +72.67% |
| 2013-12-31 | $2.57 Million | -80.24% |
| 2012-12-31 | $13.00 Million | +134.30% |
| 2011-12-31 | $5.55 Million | -3.23% |
| 2010-12-31 | $5.73 Million | +119.24% |
| 2009-12-31 | $2.62 Million | +56.87% |
| 2008-12-31 | $1.67 Million | -23.78% |
| 2007-12-31 | $2.19 Million | -67.26% |
| 2006-12-31 | $6.68 Million | +38.16% |
| 2005-12-31 | $4.83 Million | -5.03% |
| 2004-12-31 | $5.09 Million | +22.50% |
| 2003-12-31 | $4.16 Million | +183.88% |
| 2002-12-31 | $1.46 Million | +15.09% |
| 2001-12-31 | $1.27 Million | -14.92% |
| 2000-12-31 | $1.50 Million | -0.33% |
| 1999-12-31 | $1.50 Million | +36.36% |
| 1998-12-31 | $1.10 Million | +37.50% |
| 1997-12-31 | $800.00K | -27.27% |
| 1996-12-31 | $1.10 Million | -86.75% |
| 1995-12-31 | $8.30 Million | -- |